Trials / Terminated
TerminatedNCT02475369
Pancreatic Enzyme Supplementation for Celiac Disease
Pilot Study of the Efficacy of Pancreatic Enzyme Supplementation for Symptom Control in Celiac Disease Not Responding to the Gluten Free Diet
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this protocol is to conduct a pilot study to investigate whether pancreatic enzyme supplementation will improve symptoms in individuals with celiac disease who suffer persistent symptoms despite a gluten free diet. This protocol specifically aims to: 1. Evaluate the efficacy of pancreatic enzyme supplementation for reduction of gastrointestinal symptoms in patients with celiac disease on a gluten free diet. 2. Assess the ability of fecal elastase levels to predict response to pancreatic enzyme supplementation in patients with celiac disease on a gluten free diet.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pancrelipase |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2019-06-01
- Completion
- 2019-12-01
- First posted
- 2015-06-18
- Last updated
- 2021-05-12
- Results posted
- 2021-02-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02475369. Inclusion in this directory is not an endorsement.